Past performance is not indicative of future performance. An investor should consider the fund’s investment objective, risks, charges and expenses carefully before investing. To the extent any portion ...

The Boards of Directors of Flaherty & Crumrine Preferred and Income Fund Incorporated (NYSE: PFD), Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated (NYSE: PFO), Flaherty & ...

A call has been made for a new classification of ischemic stroke for patients who have a patent foramen ovale (PFO) that is thought to have been the likely cause of the stroke. The new classification ...

Flaherty & Crumrine Preferred Income Opportunity Fund (PFO) declares $0.0546/share monthly dividend, in line with previous.

I rate PFO a buy due to its attractive discount to NAV and a compelling 6.6% dividend yield for income-focused investors. PFO's performance is highly sensitive to interest rates; future rate cuts ...

Patent foramen ovale (PFO) closure in conjunction with optimal medical therapy can reduce both the number of migraine days and the frequency of attacks compared with medicine alone, according to a new ...

ATLANTA -- Scenarios for patent foramen ovale (PFO) closure not covered by the pivotal trials were a key subject of guidelines released by the Society for Cardiovascular Angiography and Interventions ...

A meta-analysis of two randomized studies evaluating patent foramen ovale (PFO) closure as a treatment strategy for migraine has shown significant benefits in several key endpoints, prompting the ...

In scuba divers with large patent foramen ovale (PFO), transcatheter closure seems to prevent decompression sickness (DCS), a new study suggests. “According to our data, PFO closure is recommended in ...

Patent foramen ovale (PFO) may be associated with migraine, especially migraine with aura (MA), when the PFO is permanent right-left shunt (RLS), large RLS, and large-size PFO, a recent study found.